The Combination of Adenoviral HSV TK Gene Therapy and Radiation is Effective in Athymic Mouse Glioblastoma Xenografts without Increasing Toxic Side Effects
- 64 Downloads
Object: In mouse models of prostate and breast cancer therapeutic effects are enhanced when adenoviral HSV TK gene therapy is combined with ionizing radiation. In the present study, we adopted this approach for the treatment of human glioblastoma xenografts in an athymic mouse model and assessed treatment results as well as toxic side effects.
Methods: About 72 nude mice received intracerebral inoculations of 2 × 105 U87ΔEGFR cells. On day 7 after tumor implantation the study population was randomized into six treatment arms: (1) intratumoral buffer inoculation on day 7, (2) intratumoral adenoviral vector injection (2 × 109 vp) on day 7, (3) single dose radiation (2.1 Gy) on day 9, (4) adenoviral injection + radiation, (5) adenoviral injection + ganciclovir (GCV) (20 ug/g twice daily from day 8 to 17), (6) adenoviral injection + GCV + radiation. On day 21 half of the animals were sacrificed for histological evaluation of the brain tumors, the other half was assessed for survival.
Results: This study showed significantly prolonged median survival time of 5 days for the GCV treated groups. The addition of radiation decreased the frequency of neurological symptoms and delayed the onset of deficits without altering the expression of thymidine kinase in the tumor cells.
Conclusions: We conclude that adenoviral HSV TK gene therapy in combination with adjuvant radiotherapy does not generate increased toxic side effects in glioblastoma treatment. The prolonged survival time of animals receiving gene therapy and the reduced occurrence of neurological symptoms in irradiated mice constitute promising features of the combined treatment.
Unable to display preview. Download preview PDF.
- 1.Kaaijk P, Troost D, Sminia P, Hulshof MCCM, van der Kracht AHW, Leenstra S, Bosch DA: Hypofractionated radiation induces a decrease in cell proliferation but no histological damage to organotypic multicellular spheroids of human glioblastoma. Eur J Cancer 33(4): 645–651, 1997CrossRefPubMedGoogle Scholar
- 3.Goodman JC, Trask TW, Chen S-H, Woo SLC, Grossman RG, Carey KD, Hubbard GB, Carrier DA, Rajagopalan S, Aguilar-Cordova E, Shine HD: Adenoviralmediated thymidine kinase gene transfer into the primate brain followed by systemic ganciclovir: pathologic, radiologic, and molecular studies. Hum Gene Ther 7: 1241–1250, 1996PubMedGoogle Scholar
- 5.Eck SL, Alavi JB, Judy K, Phillips P, Alavi A, Hackney D, Cross P, Hughes J, Gao GP, Wilson JM, Propert K: Treatment of recurrent or progressive malignant glioma with a recombinant adenovirus expressing human interferon-beta (H5.010CMVIFN-β): a phase I trial. Hum Gene Ther 12: 97–113, 2001PubMedGoogle Scholar
- 7.Packer RJ, Raffel C, Villablanca JG, Tonn JC, Burdach SE, Burger K, LaFond D, McComb JG, Cogen PH, Vezina G, Kapeala LP: Treatment of progressive or recurrent pediatric malignant supratentorial brain tumors with herpes simplex virus thymidine kinase gene vector–producer cells followed by intravenous ganciclovir administration. J Neurosurg 92: 249–254, 2000PubMedGoogle Scholar
- 11.Vlachaki MT, Chhikara M, Aguilar L, Zhu X, Chiu KJ, Woo S, Teh BS, Thompson TC, Butler EB, Aguilar-Cordova E: Enhanced therapeutic effect of multiple injections of HSV-TK + GCV gene therapy in combination with ionizing radiation in a mouse mammary tumor model. Int J Radiat Oncol Biol Phys 51(4): 1008–1017, 2001CrossRefPubMedGoogle Scholar
- 12.Chhikara M, Huang H, Vlachaki MT, Zhu X, Teh B, Chiu KJ, Woo S, Berner B, O'Brian Smith E, Oberg KC, Aguilar LK, Thompson TC, Butler EB, Aguilar-Cordova E: Enhanced therapeutic effect of HSV-TK+GCV gene therapy and ionizing radiation for prostate cancer. Mol Ther 3: 536–542, 2001CrossRefPubMedGoogle Scholar
- 13.Ikeda K, Ichikawa T, Wakimoto H, Silver JS, Deisboeck TS, Finkelstein D, Harsh GR IV, Louis DN, Bartus RT, Hochberg FH, Chiocca EA: Oncolytic virus therapy of multiple tumors in the brain requires suppression of innate and elicited antiviral responses. Nature Med 5(8): 881–887, 1999PubMedGoogle Scholar
- 15.Groenvik C, Capala J, Carlsson J: The non-variation in radiosensitivity of different proliferative states of human glioma cells. Anticancer Res 16(1): 25–31, 1996Google Scholar
- 16.Zoelzer F, Streffer C: Quiescence in S-phase and G1 arrest induced by irradiation and/or hyperthermia in six human tumour cell lines of different p53 status. Int J Radiat Biol 76(5): 717–725, 2000Google Scholar
- 18.Valter MM, Hügel A, Huang HJS, Cavenee WK, Wiestler OD, Pietsch T, Wernert N: Expression of the Ets-1 transcription factor in human astrocytomas is associated with Fms-like tyrosine kinase-1 (Flt-1)/Vascular Endothelial Growth Factor receptor-1 synthesis and neoangiogenesis. Cancer Res 59: 5608–5614, 1999PubMedGoogle Scholar
- 19.Kleihues P, Cavenee WK (eds): Tumours of the Nervous System. Pathology & Genetics, IARC Press, Lyon, 2000Google Scholar
- 22.Nofech-Mozes Y, Yuhas Y, Kaminsky E, Weizman A, Ashkenazi S: Induction of mRNA for tumor necrosis factor-alpha and interleukin-1 beta in mice brain, spleen and liver in an animal model of Shigella-related seizures. IsrMed Assoc J 2000 2(2): 86–90, 2000Google Scholar